Suppr超能文献

[肺癌的综合治疗]

[Combined-modality therapy for lung cancer].

作者信息

Miura Satoru, Yamamoto Nobuyuki

机构信息

Division of Thoracic Oncology, Shizuoka Cancer Center.

出版信息

Nihon Rinsho. 2010 Jun;68(6):1121-8.

Abstract

Lung cancer is treated with surgery, radiotherapy and chemotherapy according to histology and clinical stage. Advanced stage lung cancer patients cannot be cured, but early and locally-advanced stage patients can be cured by intensive combined-modality therapy. Combined-modality therapy with surgery plus adjuvant chemotherapy is standard for resectable IB-IIIA non-small cell lung cancer (NSCLC) and stage I small cell lung cancer (SCLC) patients. Chemoradiotherapy is standard for unresectable locally-advanced NSCLC and limited-stage SCLC patients. Recently, several new drugs, molecular targeted drugs, have become available for clinical use and trials. We reviewed standard and new strategy of combined-modality therapy for early and locally-advanced lung cancer patients.

摘要

肺癌根据组织学类型和临床分期采用手术、放疗和化疗进行治疗。晚期肺癌患者无法治愈,但早期和局部晚期患者可通过强化综合治疗治愈。手术加辅助化疗的综合治疗是可切除的IB-IIIA期非小细胞肺癌(NSCLC)和I期小细胞肺癌(SCLC)患者的标准治疗方法。放化疗是不可切除的局部晚期NSCLC和局限期SCLC患者的标准治疗方法。最近,几种新药,即分子靶向药物,已可用于临床使用和试验。我们回顾了早期和局部晚期肺癌患者综合治疗的标准和新策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验